Myofibrillar myopathies (MFMs) are genetically heterogeneous dystrophies characterized by disintegration of Z-disks and myofibrils. The characteristic degradation of myofibrils is followed by ectopic accumulation of multiple proteins. MFMs have been associated with mutations in genes encoding Z-disk or Z-disk-related proteins. Recently, BAG3 mutation has been described as causative of MFM. At now, the genetic basis of MFM with BAG 3 mutation is not fully traced. In this work we studied by exome sequencing a MFM female patient carrying the c.626 C>T (P209L) mutation in BAG3 gene. We found that this BAG3 variant is associated to mutations of N-RAP and FHL1 genes that encode muscle specific LIM domain containing proteins resulting in a decreas...
The term myofibrillar myopathies (MFM) refers to uncommon neuromuscular disorders that pathologicall...
Recent human genetic studies have provided evidences that sporadic or inherited missense mutations i...
The molecular diagnosis of muscle disorders is challenging: genetic heterogeneity (>100 causal genes...
Myofibrillar myopathies (MFMs) are genetically heterogeneous dystrophies characterized by disintegra...
Myofibrillar myopathies (MFMs) are genetically heterogeneous dystrophies characterized by the disint...
OBJECTIVE: Myofibrillar myopathies (MFMs) are morphologically distinct but genetically heterogeneou...
BACKGROUND: Myofibrillar myopathies (MFM) are a subgroup of protein aggregate myopathies (PAM) chara...
Background: Myofibrillar myopathies (MFM) are a group of phenotypically and genetically heterogeneou...
International audienceMyofibrillar myopathies (MFM) are a group of phenotypically and genetically he...
Introduction: Reducing body myopathy is a rare X-linked myopathy. It is characterized by intracytopl...
Myofibrillar myopathies are a heterogeneous group of neuromuscular disorders characterized by degene...
Myofibrillar myopathies (MFMs) are rare genetic and slowly progressive neuromuscular disorders. Seve...
Emmanuele, Valentina et al.© The Author 2014. Published by Oxford University Press. All rights reser...
FHL1 mutations cause several clinically heterogeneous myopathies, including reducing body myopathy (...
The term myofibrillar myopathies (MFM) refers to uncommon neuromuscular disorders that pathologicall...
The term myofibrillar myopathies (MFM) refers to uncommon neuromuscular disorders that pathologicall...
Recent human genetic studies have provided evidences that sporadic or inherited missense mutations i...
The molecular diagnosis of muscle disorders is challenging: genetic heterogeneity (>100 causal genes...
Myofibrillar myopathies (MFMs) are genetically heterogeneous dystrophies characterized by disintegra...
Myofibrillar myopathies (MFMs) are genetically heterogeneous dystrophies characterized by the disint...
OBJECTIVE: Myofibrillar myopathies (MFMs) are morphologically distinct but genetically heterogeneou...
BACKGROUND: Myofibrillar myopathies (MFM) are a subgroup of protein aggregate myopathies (PAM) chara...
Background: Myofibrillar myopathies (MFM) are a group of phenotypically and genetically heterogeneou...
International audienceMyofibrillar myopathies (MFM) are a group of phenotypically and genetically he...
Introduction: Reducing body myopathy is a rare X-linked myopathy. It is characterized by intracytopl...
Myofibrillar myopathies are a heterogeneous group of neuromuscular disorders characterized by degene...
Myofibrillar myopathies (MFMs) are rare genetic and slowly progressive neuromuscular disorders. Seve...
Emmanuele, Valentina et al.© The Author 2014. Published by Oxford University Press. All rights reser...
FHL1 mutations cause several clinically heterogeneous myopathies, including reducing body myopathy (...
The term myofibrillar myopathies (MFM) refers to uncommon neuromuscular disorders that pathologicall...
The term myofibrillar myopathies (MFM) refers to uncommon neuromuscular disorders that pathologicall...
Recent human genetic studies have provided evidences that sporadic or inherited missense mutations i...
The molecular diagnosis of muscle disorders is challenging: genetic heterogeneity (>100 causal genes...